Publications

A Multi-Site Study of an 18-24h Susceptibility System to the CLSI Microdilution Method for Acinetobacter spp., Pseudomonas spp. and Pseudomonas aeruginosa vs. Colistin(COL) and Polymixin B (POL), Lead author: Holliday, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Proposed MIC Quality Control Ranges for CEM-101 Using the CLSI Multi-Laboratory M23-A2 Study Design, Lead author: Rhomberg PR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Tigecycline In Vitro Susceptibility Test Accuracy Using Three Methods and USA-FDA Interpretive Criteria When Testing Japanese Clinical Isolates (2007), Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

TR-700, a Novel Oxazolidinone, Tested Against Linezolid-Resistant Gram-positive Species with Well-Characterized Resistance Mechanisms, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Novel Nanoemulsion Antimicrobials Tested Against Nine Gram-Positive Species, Lead author: Sutcliffe, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Activity of Nanoemulsions Tested Against Seven Gram-Negative Species, Lead author: Fritsche TR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Characterization of CEM-101 Activity Against 331 Respiratory Tract Pathogens Including Multidrug-Resistant Pneumococcal Serogroup 19A (MDR-19A) Isolates, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Characterization of CEM-101: Activity Against Enterococci, Uncommon Gram-positive Pathogens, N. gonorrhoeae and Anaerobes, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Characterization of CEM-101: Potential Application Against Species Causing Enteritis/Gastroenteritis, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Characterization of CEM-101: PAE, Bactericidal Activity and Combinations, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Antimicrobial Characterization of CEM-101: Single Step, Selection by Passaging and Inducible Resistances, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Assessment of CEM-101 Susceptibility Testing Conditions and Optimization of Disk Diffusion Methods, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Proposed Quality Control (QC) Parameters for Disk Diffusion (DD) Tests with Anidulafungin, Lead author: Jones RN, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Voriconazole Activity Against Aspergillus spp: Eight Years of Global Surveillance, Lead author: Diekema DJ, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Activity of Anidulafungin and Other Antifungal Agents: Results from an International Fungal Surveillance Program (2006-2007), Lead author: Fritsche TR, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Activity of Daptomycin Tested against Gram-positive Clinical Strains with Acquired Resistance to Linezolid, Lead author: Sader HS, presented at 48th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and 46th Annual Infectious Diseases Society of America (IDSA), October 25 – 28, 2008, Washington, DC

Multicenter Retrospective Evaluation of Tigecycline Tested Against Clinical Pathogens from Japan (2003-2004), Lead author: Kohno, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

OXA- and MBL-Type Enzymes Among Uncommonly Isolated Acinetobacter Spp. in Asia-Pacific Nations: Natural Reservoir for Resistance Determinants, Lead author: Mendes RE, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Comparative in Vitro Activity of Zabofloxacin (DW-224a) Tested Against Multidrug-Resistant Neisseria gonorrhoeae, Lead author: Jones RN, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Dalbavancin Activity Tested Against a Contemporary Collection of Gram-positive Bacteria from Hospitals in the UK and Ireland: Results from DECIDE Program, Lead author: Cormican, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Dalbavancin and Selected Comparison Agents Tested Against Indicated Gram-positive Isolates in European Medical Centers (Italy): Results from the DECIDE Program, Lead author: Debbia, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Dalbavancin Comparative Activity Tested Against Gram-positive Species in German Medical Centers: Results from the DECIDE Program, Lead author: Just-Nuebling, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Activity of Telavancin Against Contemporary Streptococcus spp. Pathogens: Recent Results from a European Surveillance Program (2007), Lead author: Fritsche TR, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Antimicrobial Activity of Daptomycin Tested Against Multidrug-Resistant Gram-Positive Strains Collected in European Hospitals (2003-2007), Lead author: Sader HS, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Antimicrobial Activity of Daptomycin and Comparator Agents Tested Against Gram-positive Organisms from Hong Kong, Indonesia, Philippines, Singapore and Thailand, Lead author: Turnidge JD, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Daptomycin Activity Tested Against Gram-positive Bacteria Isolated from Medical Centers Located in China (2006), Lead author: Chen, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Multicenter Evaluation of Tigecycline Activity in India: Report from the SENTRY Antimicrobial Surveillance Program (2006), Lead author: Jones RN, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Multicenter Evaluation of Tigecycline: An in Vitro Update Against Clinical Pathogens from Japan (2006-2007), Lead author: Kohno, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Dalbavancin Tested Against Staphylococcus spp. and Streptococcus spp. Isolates collected from Five European Counties: Comprehensive DECIDE Program Results (2007), Lead author: Biedenbach DJ, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Activity of Tigecycline against Clinical Pathogens Collected in Indonesia (2006), Lead author: Turnidge JD, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Tigecycline Activity against Isolates from Medical Centers Located in China, Hong Kong and Taiwan (2006): A SENTRY Antimicrobial Surveillance Program Report, Lead author: Chen, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Antimicrobial Activity of Tigecycline Tested against Contemporary Bacterial Isolates Collected in Australia (2006), Lead author: Bell JM, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

A Multi-Site Study of a Broth Cefoxitin Screen Test Using TREK Sensititre® 18-24 Hour Dried Susceptibility Plates for Predicting the Presence of mecA-Mediated Resistance in Staphylococcus aureus, Lead author: Knapp C, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Detection of cfr rRNA Methyltransferases among Staphylococcus aureus and Coagulase-Negative Staphylococci Recovered from Human Infections, Lead author: Castanheira M, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Worldwide Generic Piperacillin/Tazobactam (P/T) Comparison to Branded Product: A Contemporary Assessment of 31 Intravenous Formulations, Lead author: Moet G, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Multi-Center Surveillance Results (3,617 strains) Comparing the Gram-Positive Activity of Dalbavancin in the United States and Europe During 2005-2007, Lead author: Biedenbach DJ, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Comparative Activity of Meropenem and Other Broad-Spectrum Antimicrobials: Resistance Surveillance Testing Results from the USA MYSTIC Program (2007), Lead author: Rhomberg PR, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Linezolid Experience and Accurate Determination of Resistance (LEADER) Program 2007: Assessing Oxazolidinone and Inducible Clindamycin Resistance, Lead author: Ross JE, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Antimicrobial Activity of Doripenem Against Leading Bacterial Pathogens: Results from a Latin American Surveillance Study (2003-2006), Lead author: Gales AC, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Regression Analysis of MIC Versus Disk Diffusion Zone Diameters for Three Carbapenems Tested against Enterobacteriaceae Isolates Harboring Serine Carbapenemases with Matched Control Strains, Lead author: Fritsche TR, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Proposed Susceptibility Testing Criteria for H. influenzae Tested Against Piperacillin/Tazobactam: Report Using Results from the SENTRY Program and Japan Surveillance Isolates, Lead author: Jones RN, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

In vitro activity of tigecycline tested against pneumonia pathogens from patients hospitalised in European medical centres, including multidrug-resistant Acinetobacter spp., Lead author: Sader HS, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Tigecycline activity tested against bacterial isolates causing bloodstream infections in European medical centres, Lead author: Sader HS, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Analysis of resistance and vancomycin &quotreverse creep&quot in Latin American Staphylococcus aureus: ten-year report of the SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Picao, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Frequency and antimicrobial susceptibility profile of vancomycin-resistant enterococci from Latin America: a report from the SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Gales AC, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Prevalence of vancomycin-resistant Enterococcus spp. and associated resistance patterns among isolates collected over a decade of SENTRY Program surveillance in North America, Lead author: Castanheira M, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Genetic characterisation of the new blaVIM-18 and comparative antimicrobial susceptibility profile of VIM-18 with highest homologous VIM-variant, VIM-2: report from the SENTRY Antimicrobial Surveillance Program, Lead author: Castanheira M, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

High carbapenem resistance among Pseudomonas aeruginosa from India: a national epidemic of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, -11 and new VIM-18), Lead author: Castanheira M, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

bla_VIM-2-carrying integron among Enterobacteriaceae isolates in Mexico: report from the SENTRY Antimicrobial Surveillance Program, Lead author: Deshpande LM, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Wide variation in rates of ESBL production among Escherichia coli causing bacteraemia in the Asia-Pacific region: A SENTRY Program Report, Lead author: Bell JM, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain